Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
Swiss Medical Weekly
|
November 27, 2010
Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents
Richard F Pollock, William J Valentine, Gordon Goodall, et al.
Journal of Medical Economics
|
September 26, 2017
Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables
Wendy S Lane, James Weatherall, Jens Gundgaard, et al.
Clinical and Translational Allergy
|
November 26, 2022
ITULAZAX<sup>®</sup> versus Alutard SQ<sup>®</sup> in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost-minimization modeling analysis from the Danish societal perspective
Steen M Rønborg, Tobias Sydendal Grand, Henrik Brandi, et al.
Current Medical Research and Opinion
|
April 15, 2010
Systematic review of the cost-effectiveness of biphasic insulin aspart 30 in type 2 diabetes
William J Valentine, Richard F Pollock, Juliette Plun-Favreau, et al.
Advances in Therapy
|
September 2, 2020
Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis
Ataru Igarashi, Barnaby Hunt, Lars Wilkinson, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
February 10, 2023
A Cost-Utility Analysis of SQ<sup>®</sup> Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective
Richard F Pollock, Andreas K Slættanes, Henrik Brandi, et al.
Expert Review of Anticancer Therapy
|
September 15, 2020
Association between objective response rate and overall survival in metastatic neuroendocrine tumors treated with radioembolization: a systematic literature review and regression analysis
Richard F Pollock, Victoria K Brennan, Ralph Peters, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 30, 2021
Effects of Trial Population Selection on Quality of Life and Healthcare Decision-Making: A Systematic Review and Example in the Treatment of Hepatocellular Carcinoma with Radioembolization
Richard F Pollock, Fabien Colaone, Suki Shergill, et al.
Journal of Medical Economics
|
February 19, 2020
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK
Richard F Pollock, Fabien Colaone, Laura Guardiola, et al.
Medical Devices (Auckland, N.Z.)
|
August 16, 2013
Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis
Richard F Pollock, Yujun Qian, Tami Wisniewski, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
Swiss Medical Weekly
|
November 27, 2010
Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents
Richard F Pollock, William J Valentine, Gordon Goodall, et al.
Journal of Medical Economics
|
September 26, 2017
Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables
Wendy S Lane, James Weatherall, Jens Gundgaard, et al.
Clinical and Translational Allergy
|
November 26, 2022
ITULAZAX<sup>®</sup> versus Alutard SQ<sup>®</sup> in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost-minimization modeling analysis from the Danish societal perspective
Steen M Rønborg, Tobias Sydendal Grand, Henrik Brandi, et al.
Current Medical Research and Opinion
|
April 15, 2010
Systematic review of the cost-effectiveness of biphasic insulin aspart 30 in type 2 diabetes
William J Valentine, Richard F Pollock, Juliette Plun-Favreau, et al.
Advances in Therapy
|
September 2, 2020
Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis
Ataru Igarashi, Barnaby Hunt, Lars Wilkinson, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
February 10, 2023
A Cost-Utility Analysis of SQ<sup>®</sup> Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective
Richard F Pollock, Andreas K Slættanes, Henrik Brandi, et al.
Expert Review of Anticancer Therapy
|
September 15, 2020
Association between objective response rate and overall survival in metastatic neuroendocrine tumors treated with radioembolization: a systematic literature review and regression analysis
Richard F Pollock, Victoria K Brennan, Ralph Peters, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 30, 2021
Effects of Trial Population Selection on Quality of Life and Healthcare Decision-Making: A Systematic Review and Example in the Treatment of Hepatocellular Carcinoma with Radioembolization
Richard F Pollock, Fabien Colaone, Suki Shergill, et al.
Journal of Medical Economics
|
February 19, 2020
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK
Richard F Pollock, Fabien Colaone, Laura Guardiola, et al.
Medical Devices (Auckland, N.Z.)
|
August 16, 2013
Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis
Richard F Pollock, Yujun Qian, Tami Wisniewski, et al.
Page
of 9